4579 — RaQualia Pharma Share News
0.000.00%
Table: RaQualia Pharma - 9-MTH group results
Table: RaQualia Pharma -2019 group forecast
Table: RaQualia Pharma - 6-MTH group results
Table: RaQualia Pharma -Q1 group results
Table: RaQualia Pharma -2018 group results
Table: RaQualia Pharma -2018 parent results
Table: RaQualia Pharma -2018 parent forecast
Table: RaQualia Pharma -2018 group forecast
Table: RaQualia Pharma - 9-MTH group results
Table: RaQualia Pharma -2018 group forecast
Table: RaQualia Pharma - 6-MTH group results
Brief: RaQualia Pharma says status of formation of JV with ZTE Coming Biotech
Brief: RaQualia Pharma updates establishment of pharmaceutical JV with ZTE Coming Biotech
Table: RaQualia Pharma -Q1 group results
Brief: RaQualia Pharma says license agreement for novel P2X7 receptor antagonist
Table: RaQualia Pharma -2017 group results
Table: RaQualia Pharma -2017 parent results
Table: RaQualia Pharma -2017 group forecast
Brief: RaQualia Pharma plans pharmaceutical JV with ZTE Coming Biotech